Skip to main content
. 2021 Jul 24;127:103382. doi: 10.1016/j.jue.2021.103382

Table 3.

Characteristics of federal pharmacy and state vaccine sites.

<1 mile <1 mile <1 mile <5 miles <5 miles <5 miles
State state state + state + state state + state +
pharm pharm + pharm pharm +
DG DG
AK 37.73 37.97 37.97 58.66 58.66 58.66
AL 22.58 35.91 51.98 73.82 76.98 93.58
AR 27.23 31.51 48.14 71.46 73.78 87.63
CT 48.38 72.19 74.62 93.51 97.94 98.65
GA 13.67 32.74 47.5 69.34 84.29 95.97
IL 24.29 69.97 77.11 84.81 90.65 96.37
KS 15.18 47.38 61.80 53.16 81.63 90.28
MD 30.60 69.59 74.34 81.88 94.37 97.30
ME 14.19 33.56 35.75 38.58 64.70 73.47
MO 48.12 56.33 64.81 81.15 84.23 92.02
MS 22.63 35.77 49.78 60.01 68.23 87.16
ND 50.53 50.53 51.12 72.60 72.60 74.11
NJ 38.56 79.29 81.96 90.52 99.07 99.69
NV 41.44 77.65 79.64 88.97 92.31 93.16
OH 40.06 65.82 74.44 87.85 92.25 97.29
OK 20.95 43.17 62.76 65.42 78.41 92.85
PA 30.29 69.19 73.94 81.5 92.76 97.68
SC 11.73 31.37 46.81 59.29 78.69 93.86
WA 28.39 55.59 55.70 80.49 88.75 88.85
WV 3.16 23.10 37.63 13.47 70.11 87.03

Notes: Share of low-income households less than one mile/5 miles from state sites, pharmacy partners plus state vaccine sites, and pharmacy partners plus state vaccine sites plus DG. Data from RefUSA and state vaccine sites.